US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

11.19

+0.06500.58%

Post-market: 11.190.00000.00%19:45 EDT

Volume:168.59K

Turnover:1.89M

Market Cap:547.03M

PE:-3.49

High:11.34

Open:11.02

Low:10.94

Close:11.13

52wk High:14.53

52wk Low:2.22

Shares:48.89M

Float Shares:19.90M

Volume Ratio:0.60

T/O Rate:0.85%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2084

EPS(LYR):-3.4309

ROE:-36.58%

ROA:-22.34%

PB:1.57

PE(LYR):-3.26

Loading ...

Overview Company News Filings

RA Capital Management Reports $1.43 Million Purchase of Artiva Biotherapeutics Shares

Artiva Biotherapeutics Issues 288,800 Rsus to 17 New Hires Under Inducement Plan

Artiva Biotherapeutics Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RA Capital Management Reports Purchase of Artiva Biotherapeutics Common Shares Worth $194,237.66

Major Stake Boost Signals Growing Confidence in Artiva Biotherapeutics

RA Capital Management Reports $292,129 Artiva Biotherapeutics Common Share Purchase

Artiva Biotherapeutics to join H.C. Wainwright Cell Therapy Virtual Conference fireside chat

RA Capital Management reports USD 4.56 million Artiva Biotherapeutics common stock acquisition

RA Capital Management acquires Artiva Biotherapeutics common shares worth $8.19 million

Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV), MoonLake Immunotherapeutics (MLTX) and MBX Biosciences, Inc. (MBX)

Artiva Biotherapeutics Price Target Maintained With a $41.00/Share by Needham

Needham Sticks to Its Buy Rating for Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics highlights AlloNK data presented at EULAR 2026

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Major Investor Makes Bold Move Into Artiva Biotherapeutics Stock

GC Corp acquires USD 12.5 million of Artiva Biotherapeutics common shares

Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV) and Phreesia (PHR)

Artiva says AB-101 plus rituximab posts 71% ACR50 response in refractory RA study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/ARTV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":11.19,"timestamp":1788552000000,"preClose":11.125,"halted":0,"volume":168592,"hourTrading":{"tag":"盘后","latestPrice":11.19,"preClose":11.19,"latestTime":"19:45 EDT","volume":3802,"amount":42541.43,"timestamp":1788565527123,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.005842696629213439,"floatShares":19899500,"shares":48885777,"eps":-3.20842,"marketStatus":"Market Closed","change":0.065,"latestTime":"09-04 16:00:00 EDT","open":11.02,"high":11.34,"low":10.94,"amount":1886015.9440799998,"amplitude":0.035955,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.20842,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"listingDate":1721361600000,"exchange":"NASDAQ","adjPreClose":11.125,"preHourTrading":{"tag":"盘前","latestPrice":11.03,"preClose":11.125,"latestTime":"09:29 EDT","volume":1758,"amount":19508.946162,"timestamp":1788528599985,"change":-0.095,"changeRate":-0.008539,"amplitude":0.015272},"postHourTrading":{"tag":"盘后","latestPrice":11.19,"preClose":11.19,"latestTime":"19:45 EDT","volume":3802,"amount":42541.43,"timestamp":1788565527123,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5960119746881601,"impliedVol":1.2732,"impliedVolPercentile":0.6364},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","floatShares":19899500,"roa":"-22.34%","roe":"-36.58%","lyrEps":-3.430895,"volumeRatio":0.5960119746881601,"shares":48885777,"dividePrice":0,"high":11.34,"amplitude":0.035955,"preClose":11.125,"low":10.94,"week52Low":2.22,"pbRate":"1.57","week52High":14.53,"institutionHeld":0,"latestPrice":11.19,"eps":-3.20842,"divideRate":0,"volume":168592,"delay":0,"ttmEps":-3.20842,"open":11.02,"prevYearClose":4.29,"prevWeekClose":11.09,"prevMonthClose":11.3,"prevQuarterClose":9.7,"fiveDayClose":11.09,"twentyDayClose":11.27,"sixtyDayClose":7.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ARTV","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-08","symbol":"ARTV","fiscalQuarterEnding":"2026/03","expectedEps":-0.88,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2026-03-10","symbol":"ARTV","fiscalQuarterEnding":"2025/12","expectedEps":-0.87,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2025-11-12","symbol":"ARTV","fiscalQuarterEnding":"2025/09","expectedEps":-0.92,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.88},{"market":"US","date":"2025-08-06","symbol":"ARTV","fiscalQuarterEnding":"2025/06","expectedEps":-0.84,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.87}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1735617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARTV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARTV","date":"2026-09-04","current":-3.487698,"percent":0.176245,"low":-11.820615,"twenty":-5.513396,"median":-1.759981,"eighty":-0.947685,"high":-0.499349,"avg":-3.291817,"sd":2.974559,"marketCap":543902596},"quantilePoints":[{"date":"2024-08-02","current":-10.391793,"twenty":-10.391793,"median":-10.391793,"eighty":-10.391793,"marketCap":269833291},{"date":"2024-08-09","current":-9.862789,"twenty":-10.391793,"median":-10.042112,"eighty":-9.943484,"marketCap":256097171},{"date":"2024-08-16","current":-10.185571,"twenty":-10.248334,"median":-10.131774,"eighty":-9.95245,"marketCap":264478532},{"date":"2024-08-23","current":-8.939273,"twenty":-10.248334,"median":-10.051078,"eighty":-9.342751,"marketCap":232117163},{"date":"2024-08-30","current":-8.088598,"twenty":-10.185571,"median":-9.943484,"eighty":-9.046867,"marketCap":263081639},{"date":"2024-09-06","current":-8.893463,"twenty":-10.142533,"median":-9.800025,"eighty":-8.930111,"marketCap":289259885},{"date":"2024-09-13","current":-8.019798,"twenty":-10.131774,"median":-9.459311,"eighty":-8.763533,"marketCap":260843926},{"date":"2024-09-20","current":-8.759053,"twenty":-10.07439,"median":-9.028935,"eighty":-8.450238,"marketCap":284888199},{"date":"2024-09-27","current":-9.946342,"twenty":-10.07439,"median":-9.323455,"eighty":-8.581333,"marketCap":323504758},{"date":"2024-10-04","current":-11.499524,"twenty":-10.277026,"median":-9.57298,"eighty":-8.727691,"marketCap":374022017},{"date":"2024-10-11","current":-10.566121,"twenty":-10.505561,"median":-9.728296,"eighty":-8.794895,"marketCap":343663087},{"date":"2024-10-18","current":-9.543111,"twenty":-10.587029,"median":-9.800025,"eighty":-8.869568,"marketCap":310389700},{"date":"2024-10-25","current":-7.586699,"twenty":-10.505561,"median":-9.574426,"eighty":-8.581333,"marketCap":246757383},{"date":"2024-10-31","current":-7.579232,"twenty":-10.485041,"median":-9.464706,"eighty":-8.226879,"marketCap":246514511},{"date":"2024-11-08","current":-10.424244,"twenty":-10.485041,"median":-9.3863,"eighty":-8.226879,"marketCap":339048530},{"date":"2024-11-15","current":-4.166082,"twenty":-10.46953,"median":-9.378833,"eighty":-8.149728,"marketCap":255280837},{"date":"2024-11-22","current":-4.310765,"twenty":-10.439178,"median":-9.30416,"eighty":-7.969021,"marketCap":264146442},{"date":"2024-11-29","current":-5.065892,"twenty":-10.411264,"median":-9.046867,"eighty":-7.81669,"marketCap":310417611},{"date":"2024-12-06","current":-4.598149,"twenty":-10.334409,"median":-8.970887,"eighty":-7.365669,"marketCap":281756204},{"date":"2024-12-13","current":-4.233469,"twenty":-10.223229,"median":-8.939273,"eighty":-5.058757,"marketCap":259410023},{"date":"2024-12-20","current":-3.963922,"twenty":-10.173512,"median":-8.885996,"eighty":-4.852633,"marketCap":242893280},{"date":"2024-12-27","current":-4.17401,"twenty":-10.150694,"median":-8.781454,"eighty":-4.667914,"marketCap":255766623},{"date":"2025-01-03","current":-3.95203,"twenty":-10.131774,"median":-8.549971,"eighty":-4.598149,"marketCap":242164600},{"date":"2025-01-10","current":-4.066984,"twenty":-10.131774,"median":-8.396892,"eighty":-4.398368,"marketCap":249208505},{"date":"2025-01-17","current":-2.687539,"twenty":-10.07439,"median":-8.17661,"eighty":-4.337719,"marketCap":164681643},{"date":"2025-01-24","current":-2.477451,"twenty":-10.049285,"median":-8.109405,"eighty":-4.224748,"marketCap":151808300},{"date":"2025-01-31","current":-2.140518,"twenty":-10.011532,"median":-8.012331,"eighty":-4.193829,"marketCap":131162371},{"date":"2025-02-07","current":-1.823404,"twenty":-9.967928,"median":-7.881014,"eighty":-4.108209,"marketCap":111730908},{"date":"2025-02-14","current":-1.589533,"twenty":-9.948785,"median":-7.698708,"eighty":-3.978192,"marketCap":97400205},{"date":"2025-02-21","current":-1.502326,"twenty":-9.945199,"median":-7.508293,"eighty":-3.804572,"marketCap":92056553},{"date":"2025-02-28","current":-1.478543,"twenty":-9.911206,"median":-5.18038,"eighty":-2.77871,"marketCap":90599193},{"date":"2025-03-07","current":-2.0216,"twenty":-9.837683,"median":-5.059946,"eighty":-2.521847,"marketCap":123875572},{"date":"2025-03-14","current":-2.219796,"twenty":-9.795827,"median":-4.998506,"eighty":-2.343471,"marketCap":136020236},{"date":"2025-03-21","current":-1.601424,"twenty":-9.736345,"median":-4.76067,"eighty":-2.165887,"marketCap":98128885},{"date":"2025-03-28","current":-1.319282,"twenty":-9.624289,"median":-4.665536,"eighty":-2.054897,"marketCap":86245441},{"date":"2025-04-04","current":-0.946604,"twenty":-9.574715,"median":-4.606077,"eighty":-1.965312,"marketCap":61882322},{"date":"2025-04-11","current":-0.685729,"twenty":-9.561032,"median":-4.439593,"eighty":-1.797242,"marketCap":44828138},{"date":"2025-04-17","current":-0.857161,"twenty":-9.511749,"median":-4.37617,"eighty":-1.744126,"marketCap":56035173},{"date":"2025-04-25","current":-0.913063,"twenty":-9.383313,"median":-4.344458,"eighty":-1.606181,"marketCap":59689641},{"date":"2025-05-02","current":-0.883248,"twenty":-9.365642,"median":-4.233469,"eighty":-1.560992,"marketCap":57740592},{"date":"2025-05-09","current":-0.740531,"twenty":-9.335033,"median":-4.213649,"eighty":-1.495984,"marketCap":53111599},{"date":"2025-05-16","current":-0.723546,"twenty":-9.26085,"median":-4.193829,"eighty":-1.480232,"marketCap":51893443},{"date":"2025-05-23","current":-0.672592,"twenty":-9.079462,"median":-4.170046,"eighty":-1.376675,"marketCap":48238975},{"date":"2025-05-30","current":-0.696371,"twenty":-9.046867,"median":-4.104641,"eighty":-1.177664,"marketCap":49944393},{"date":"2025-06-06","current":-0.665798,"twenty":-9.028935,"median":-3.995633,"eighty":-0.946604,"marketCap":47751713},{"date":"2025-06-13","current":-0.696371,"twenty":-8.975602,"median":-3.957976,"eighty":-0.913063,"marketCap":49944393},{"date":"2025-06-20","current":-0.570684,"twenty":-8.968058,"median":-3.829149,"eighty":-0.909336,"marketCap":40930039},{"date":"2025-06-27","current":-0.533318,"twenty":-8.961769,"median":-2.822312,"eighty":-0.881757,"marketCap":38250096},{"date":"2025-07-03","current":-0.546906,"twenty":-8.947831,"median":-2.762854,"eighty":-0.830328,"marketCap":39224621},{"date":"2025-07-11","current":-0.60805,"twenty":-8.911787,"median":-2.592405,"eighty":-0.73948,"marketCap":43609983},{"date":"2025-07-18","current":-0.879805,"twenty":-8.888983,"median":-2.477451,"eighty":-0.736237,"marketCap":63100478},{"date":"2025-07-25","current":-1.168544,"twenty":-8.885996,"median":-2.34466,"eighty":-0.73948,"marketCap":83809129},{"date":"2025-08-01","current":-1.019079,"twenty":-8.836712,"median":-2.219796,"eighty":-0.740531,"marketCap":73089357},{"date":"2025-08-08","current":-0.856075,"twenty":-8.776974,"median":-2.136554,"eighty":-0.74119,"marketCap":64318634},{"date":"2025-08-15","current":-0.877783,"twenty":-8.664966,"median":-2.104843,"eighty":-0.766227,"marketCap":65949557},{"date":"2025-08-22","current":-0.90054,"twenty":-8.539516,"median":-2.017636,"eighty":-0.794855,"marketCap":67659360},{"date":"2025-08-29","current":-1.027331,"twenty":-8.461857,"median":-1.938358,"eighty":-0.806285,"marketCap":77185407},{"date":"2025-09-05","current":-1.011075,"twenty":-8.405106,"median":-1.906646,"eighty":-0.809828,"marketCap":75964119},{"date":"2025-09-12","current":-0.864778,"twenty":-8.31765,"median":-1.769891,"eighty":-0.816568,"marketCap":64972526},{"date":"2025-09-19","current":-0.773749,"twenty":-8.226879,"median":-1.740162,"eighty":-0.790778,"marketCap":58133313},{"date":"2025-09-26","current":-0.978565,"twenty":-8.17661,"median":-1.635118,"eighty":-0.805192,"marketCap":73521543},{"date":"2025-10-03","current":-0.959059,"twenty":-8.149728,"median":-1.601424,"eighty":-0.809828,"marketCap":72055997},{"date":"2025-10-10","current":-0.975314,"twenty":-8.101082,"median":-1.571695,"eighty":-0.816568,"marketCap":73277286},{"date":"2025-10-17","current":-0.90054,"twenty":-8.061078,"median":-1.530074,"eighty":-0.825779,"marketCap":67659360},{"date":"2025-10-24","current":-1.573506,"twenty":-8.013824,"median":-1.539983,"eighty":-0.830317,"marketCap":118220688},{"date":"2025-10-31","current":-1.280912,"twenty":-7.969021,"median":-1.537745,"eighty":-0.833281,"marketCap":96237502},{"date":"2025-11-07","current":-1.11836,"twenty":-7.90156,"median":-1.498363,"eighty":-0.837688,"marketCap":84024621},{"date":"2025-11-14","current":-1.102105,"twenty":-7.858868,"median":-1.490435,"eighty":-0.847643,"marketCap":82803333},{"date":"2025-11-21","current":-0.982565,"twenty":-7.819676,"median":-1.476561,"eighty":-0.856509,"marketCap":77807345},{"date":"2025-11-28","current":-1.16544,"twenty":-7.765913,"median":-1.457948,"eighty":-0.858684,"marketCap":92288839},{"date":"2025-12-05","current":-1.170089,"twenty":-7.585206,"median":-1.427209,"eighty":-0.865066,"marketCap":92657012},{"date":"2025-12-12","current":-0.973266,"twenty":-7.550856,"median":-1.356118,"eighty":-0.866579,"marketCap":77070998},{"date":"2025-12-19","current":-1.441302,"twenty":-7.413459,"median":-1.35655,"eighty":-0.869582,"marketCap":114133803},{"date":"2025-12-26","current":-1.332817,"twenty":-7.317879,"median":-1.35655,"eighty":-0.875795,"marketCap":105543087},{"date":"2026-01-02","current":-1.329717,"twenty":-5.60788,"median":-1.355686,"eighty":-0.876285,"marketCap":105297638},{"date":"2026-01-09","current":-1.419605,"twenty":-5.08879,"median":-1.356118,"eighty":-0.877508,"marketCap":112415660},{"date":"2026-01-16","current":-1.38241,"twenty":-5.065892,"median":-1.373111,"eighty":-0.877783,"marketCap":109470271},{"date":"2026-01-23","current":-1.534289,"twenty":-5.058757,"median":-1.38241,"eighty":-0.877783,"marketCap":121497274},{"date":"2026-01-30","current":-1.286323,"twenty":-5.046865,"median":-1.38396,"eighty":-0.878996,"marketCap":101861351},{"date":"2026-02-06","current":-1.199535,"twenty":-5.015947,"median":-1.373111,"eighty":-0.880542,"marketCap":94988778},{"date":"2026-02-13","current":-1.23673,"twenty":-4.922398,"median":-1.361731,"eighty":-0.882362,"marketCap":97934166},{"date":"2026-02-20","current":-1.404107,"twenty":-4.858976,"median":-1.356118,"eighty":-0.88623,"marketCap":111188415},{"date":"2026-02-27","current":-1.689268,"twenty":-4.776526,"median":-1.370012,"eighty":-0.890736,"marketCap":133769726},{"date":"2026-03-06","current":-1.779155,"twenty":-4.679806,"median":-1.38241,"eighty":-0.892087,"marketCap":140887748},{"date":"2026-03-13","current":-1.989358,"twenty":-4.672671,"median":-1.404107,"eighty":-0.894194,"marketCap":166837536},{"date":"2026-03-20","current":-1.626853,"twenty":-4.654437,"median":-1.418531,"eighty":-0.895573,"marketCap":136436029},{"date":"2026-03-27","current":-1.520754,"twenty":-4.628275,"median":-1.425804,"eighty":-0.898589,"marketCap":127538027},{"date":"2026-04-02","current":-1.989358,"twenty":-4.610834,"median":-1.432003,"eighty":-0.90054,"marketCap":166837536},{"date":"2026-04-10","current":-2.004094,"twenty":-4.574366,"median":-1.4506,"eighty":-0.90119,"marketCap":168073369},{"date":"2026-04-17","current":-3.569056,"twenty":-4.471304,"median":-1.457173,"eighty":-0.904441,"marketCap":299318897},{"date":"2026-04-24","current":-3.330333,"twenty":-4.432458,"median":-1.470747,"eighty":-0.907501,"marketCap":279298393},{"date":"2026-05-01","current":-3.01793,"twenty":-4.398368,"median":-1.476546,"eighty":-0.909336,"marketCap":253098721},{"date":"2026-05-08","current":-3.689891,"twenty":-4.369828,"median":-1.481596,"eighty":-0.910081,"marketCap":309452733},{"date":"2026-05-15","current":-3.031745,"twenty":-4.344458,"median":-1.487795,"eighty":-0.913063,"marketCap":263974056},{"date":"2026-05-22","current":-4.458708,"twenty":-4.432458,"median":-1.494399,"eighty":-0.913063,"marketCap":388219702},{"date":"2026-05-29","current":-4.246654,"twenty":-4.403917,"median":-1.50281,"eighty":-0.913063,"marketCap":369756186},{"date":"2026-06-05","current":-4.285717,"twenty":-4.403917,"median":-1.512592,"eighty":-0.913063,"marketCap":373157360},{"date":"2026-06-12","current":-4.464288,"twenty":-4.403917,"median":-1.532182,"eighty":-0.913063,"marketCap":388705584},{"date":"2026-06-18","current":-5.546878,"twenty":-4.459824,"median":-1.539565,"eighty":-0.913448,"marketCap":482966688},{"date":"2026-06-26","current":-4.927458,"twenty":-4.618762,"median":-1.553857,"eighty":-0.916145,"marketCap":429033788},{"date":"2026-07-02","current":-5.468753,"twenty":-4.679014,"median":-1.559086,"eighty":-0.919028,"marketCap":476164340},{"date":"2026-07-10","current":-5.251119,"twenty":-4.852633,"median":-1.578076,"eighty":-0.922185,"marketCap":457214943},{"date":"2026-07-17","current":-5.044646,"twenty":-4.98936,"median":-1.593497,"eighty":-0.929149,"marketCap":439237309},{"date":"2026-07-24","current":-5.652905,"twenty":-5.058757,"median":-1.601424,"eighty":-0.93305,"marketCap":492198445},{"date":"2026-07-31","current":-5.820316,"twenty":-5.116075,"median":-1.607696,"eighty":-0.93435,"marketCap":506774905},{"date":"2026-08-07","current":-6.195168,"twenty":-5.189342,"median":-1.626853,"eighty":-0.936301,"marketCap":562651332},{"date":"2026-08-14","current":-6.082936,"twenty":-5.239958,"median":-1.667148,"eighty":-0.936301,"marketCap":552458367},{"date":"2026-08-21","current":-5.996806,"twenty":-5.366075,"median":-1.692595,"eighty":-0.938902,"marketCap":544635947},{"date":"2026-08-28","current":-6.427457,"twenty":-5.453128,"median":-1.724769,"eighty":-0.944323,"marketCap":583748044},{"date":"2026-09-04","current":-5.988732,"twenty":-5.513396,"median":-1.759981,"eighty":-0.947685,"marketCap":543902596}],"updateTime":1788598707889},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARTV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653902249","title":"RA Capital Management Reports $1.43 Million Purchase of Artiva Biotherapeutics Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2653902249","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653902249?lang=en_us&edition=fundamental","pubTime":"2026-07-21 06:09","pubTimestamp":1784585370,"startTime":"0","endTime":"0","summary":"RA Capital Management reports $1.43 million purchase of Artiva Biotherapeutics sharesRA Capital Management reported additional purchases of Artiva Biotherapeutics common stock.Total beneficial ownersh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL4Pd7LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"RA Capital Management Reports $1.43 Million Purchase of Artiva Biotherapeutics Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652694400","title":"Artiva Biotherapeutics Issues 288,800 Rsus to 17 New Hires Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2652694400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652694400?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:30","pubTimestamp":1784287816,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics issues 288,800 RSUs to 17 new hires under inducement planArtiva Biotherapeutics issued inducement grants totaling 288,800 restricted stock units to 17 new employees, effective J","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDLcpLC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","ARTV","SG9999014021.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","BCDF","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","BK4112","IE00B64PRP62.GBP","LU2095319765.USD","IE00BN0W2W23.USD","BK4585","IE00BN0W2T93.GBP","BK4588","BK4139","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652655400","title":"Artiva Biotherapeutics Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2652655400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652655400?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:30","pubTimestamp":1784287800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA38MS32:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652161400","title":"Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2652161400","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652161400?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:30","pubTimestamp":1784287800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, July  17, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therap","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/17/3329034/0/en/Artiva-Biotherapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","RA","LCLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651691482","title":"RA Capital Management Reports Purchase of Artiva Biotherapeutics Common Shares Worth $194,237.66","url":"https://stock-news.laohu8.com/highlight/detail?id=2651691482","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651691482?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:01","pubTimestamp":1784070060,"startTime":"0","endTime":"0","summary":"RA Capital Management reports purchase of Artiva Biotherapeutics common shares worth $194,237.66RA Capital Management, a director and 10% owner of Artiva Biotherapeutics, increased its stake through o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL7RkS1l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"RA Capital Management Reports Purchase of Artiva Biotherapeutics Common Shares Worth $194,237.66","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647586752","title":"Major Stake Boost Signals Growing Confidence in Artiva Biotherapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2647586752","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647586752?lang=en_us&edition=fundamental","pubTime":"2026-06-30 10:02","pubTimestamp":1782784952,"startTime":"0","endTime":"0","summary":"New insider activity at Artiva Biotherapeutics, Inc. ( ($ARTV) ) has taken place on June 29, 2026. Director Ra Capital Management, LLC has expanded...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-stake-boost-signals-growing-confidence-in-artiva-biotherapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-stake-boost-signals-growing-confidence-in-artiva-biotherapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647304080","title":"RA Capital Management Reports $292,129 Artiva Biotherapeutics Common Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2647304080","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647304080?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:21","pubTimestamp":1782764481,"startTime":"0","endTime":"0","summary":"RA Capital Management reports $292,129 Artiva Biotherapeutics common share purchaseRA Capital Management bought 32,876 Artiva Biotherapeutics common shares in open-market purchases at about USD 8.88 t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL1Rnnzm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"RA Capital Management Reports $292,129 Artiva Biotherapeutics Common Share Purchase","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645859673","title":"Artiva Biotherapeutics to join H.C. Wainwright Cell Therapy Virtual Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2645859673","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645859673?lang=en_us&edition=fundamental","pubTime":"2026-06-24 04:05","pubTimestamp":1782245152,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics will join the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference on June 30, 2026.Management is scheduled for a fireside chat at 3:30 p.m. EDT.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL87LDLK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2095319765.USD","BK4112","IE00BN0W2V16.EUR","BK4139","IE00B64PRP62.GBP","SG9999014021.USD","ARTV","BK4585","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","SG9999014039.USD","SG9999014013.SGD","BK4588","IE00BN0W2W23.USD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644400793","title":"RA Capital Management reports USD 4.56 million Artiva Biotherapeutics common stock acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2644400793","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644400793?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:08","pubTimestamp":1781647738,"startTime":"0","endTime":"0","summary":"RA Capital Management, a director-level 10% owner, reported additional purchases of Artiva Biotherapeutics common stock.Total beneficial ownership rose to 16,763,043 shares, held indirectly.Recent purchases were reported at weighted average prices of $8.57, $8.99, and $8.89.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDLgRBGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"RA Capital Management reports USD 4.56 million Artiva Biotherapeutics common stock acquisition","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642230602","title":"RA Capital Management acquires Artiva Biotherapeutics common shares worth $8.19 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2642230602","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642230602?lang=en_us&edition=fundamental","pubTime":"2026-06-12 07:37","pubTimestamp":1781221030,"startTime":"0","endTime":"0","summary":"RA Capital Management, a director-level 10% owner, increased its Artiva Biotherapeutics common stock position through open-market purchases.Buying activity was reported at prices around USD 6.91, USD 7, USD 7.91 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDLc6w13X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"RA Capital Management acquires Artiva Biotherapeutics common shares worth $8.19 million","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642058433","title":"Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV), MoonLake Immunotherapeutics (MLTX) and MBX Biosciences, Inc. (MBX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642058433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642058433?lang=en_us&edition=fundamental","pubTime":"2026-06-09 00:40","pubTimestamp":1780936810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Artiva Biotherapeutics, Inc. (ARTV), MoonLake Immuno...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-artiva-biotherapeutics-inc-artv-moonlake-immunotherapeutics-mltx-and-mbx-biosciences-inc-mbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-artiva-biotherapeutics-inc-artv-moonlake-immunotherapeutics-mltx-and-mbx-biosciences-inc-mbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","BK4139","LU0029874061.USD","LU0128526141.USD","BK4588","BK4137","BK4581","BK4585","BK4007","ARTV","MBX","MLTX","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641343339","title":"Artiva Biotherapeutics Price Target Maintained With a $41.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2641343339","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641343339?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:56","pubTimestamp":1780934160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARTV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 08, 2026 11:56 ET (15:56 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641543839","title":"Needham Sticks to Its Buy Rating for Artiva Biotherapeutics, Inc. (ARTV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641543839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641543839?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:55","pubTimestamp":1780930543,"startTime":"0","endTime":"0","summary":"Needham analyst Gil Blum reiterated a Buy rating on Artiva Biotherapeutics, Inc. today and set a price target of $41.00. Blum covers the Healthcare...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/needham-sticks-to-its-buy-rating-for-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/needham-sticks-to-its-buy-rating-for-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641485733","title":"Artiva Biotherapeutics highlights AlloNK data presented at EULAR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2641485733","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641485733?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:40","pubTimestamp":1780915249,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics (ARTV) highlighted clinical, safety and translational data for AlloNK, also known as AB-101, an allogeneic, off-the-shelf, n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-highlights-allonk-data-presented-at-eular-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-highlights-allonk-data-presented-at-eular-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641450485","title":"Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2641450485","media":"GlobeNewswire","labels":["policyRegulatory","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641450485?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:30","pubTimestamp":1780914600,"startTime":"0","endTime":"0","summary":"Multiple EULAR presentations reinforce potential of AlloNK to drive deep B-cell depletion and meaningful clinical responses across refractory rheumatoid arthritis, Sjgren disease and systemic sclerosi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/08/3307910/0/en/Artiva-Biotherapeutics-Highlights-AlloNK-Data-Presented-at-EULAR-2026-FDA-RMAT-Designation-in-Refractory-Rheumatoid-Arthritis-and-Webcast-Today.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","RA","CRS","BK4006","LABU","ARTV","IE00B7SZL793.SGD","IE0031619046.USD","IE00B19Z4B17.USD","BK4585","LU0963586101.USD","IE00B66KJ199.SGD","BK4588","BK4139","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639564385","title":"Major Investor Makes Bold Move Into Artiva Biotherapeutics Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2639564385","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639564385?lang=en_us&edition=fundamental","pubTime":"2026-05-29 10:15","pubTimestamp":1780020954,"startTime":"0","endTime":"0","summary":"New insider activity at Artiva Biotherapeutics, Inc. ( ($ARTV) ) has taken place on May 28, 2026. Significant shareholder GC Corp. has made a major...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-makes-bold-move-into-artiva-biotherapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-makes-bold-move-into-artiva-biotherapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639619308","title":"GC Corp acquires USD 12.5 million of Artiva Biotherapeutics common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2639619308","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639619308?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:36","pubTimestamp":1780000586,"startTime":"0","endTime":"0","summary":"GC Corp. reported purchases of Artiva Biotherapeutics common stock at USD 11.52 per share, lifting its direct stake to 4,391,969 shares.GC Cell Corp, an affiliate, also bought common stock at USD 11.52, increasing its indirect holdings to 1,607,734 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL2SVXZt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GC Corp acquires USD 12.5 million of Artiva Biotherapeutics common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698121","title":"Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698121","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698121?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, May  28, 2026  (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therap","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3302755/0/en/Artiva-Biotherapeutics-to-Participate-in-the-2026-Jefferies-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","BK4581","XBI","BK4139","ARTV","BK4588","LABU","LU0029874061.USD","HCSG","XLV","BK4137","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638151269","title":"Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV) and Phreesia (PHR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638151269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638151269?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:40","pubTimestamp":1779799204,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Artiva Biotherapeutics, Inc. (ARTV) and Phreesia (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-artiva-biotherapeutics-inc-artv-and-phreesia-phr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-artiva-biotherapeutics-inc-artv-and-phreesia-phr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","XLV","LU0128526141.USD","BK4588","HCSG","LABU","XBI","BK4139","BK4581","LU0029874061.USD","BK4585","BK4167","PHR","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636086127","title":"Artiva says AB-101 plus rituximab posts 71% ACR50 response in refractory RA study","url":"https://stock-news.laohu8.com/highlight/detail?id=2636086127","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636086127?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:05","pubTimestamp":1779221150,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics flagged new clinical data for its AB-101 allogeneic NK-cell therapy with rituximab, scheduled for presentation at the EULAR 2026 Congress in London on June 3–6.The late-breaking oral presentation is set to show that the regimen produced strong clinical responses in rheumatologic diseases, described as comparable to outcomes reported with autologous CAR T-cell therapy.Additional EULAR presentations are expected to highlight durable benefit in severe rheumatoid arthritis, an initial experience in severe Sjgren disease, deep B-cell depletion, and a safety profile characterized as favorable in immune-mediated diseases.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL1wKsMf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BN0W2V16.EUR","SG9999014013.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014039.USD","LU0314104364.USD","NDAQ","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","BK4588","LU2210149790.SGD","LU2210150020.SGD","SG9999014021.USD","BK4585","ARTV","LU2095319765.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":88,"code":"91000000","status":"200"}]}}